MDxHealth Adds Galaxy to Payor Network | GenomeWeb

NEW YORK (GenomeWeb) – MDxHealth today announced an agreement with preferred provider organization Galaxy Health Network to provide access to MDxHealth's ConfirmMDx for Prostate Cancer test.

Based in Arlington, Texas, Galaxy has a provider network of more than 400,000 physicians, 2,700 hospitals, and 47,000 ancillary providers, as well as more than 3.5 million covered lives. Today's agreement brings the total number of covered lives with access to ConfirmMDx to about 147 million in the US, MDxHealth said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Fed up with budget slashes, job cuts, and muzzling mandates, researchers in Canada are making science a campaign issue in the upcoming elections.

A former NIH program officer says the Internet has blasted open the door for scientific publications more interested in dollars than quality research.

This Week in Science: New research into the emergence of infectious diseases, and scientists report on proteins involved in melanoma.

The hashtag #stupidcommonnames is gaining fans among scientists who find the common names of animals and plants dumb.

Sep
17
Sponsored by
Omicia

This online seminar will provide examples of how commercial and hospital-affiliated clinical labs are successfully developing and deploying high-throughput next-generation sequencing-based testing services for genetic diseases. 

Oct
15
Sponsored by
Parabase

This webinar will discuss the benefits of a rapid targeted next-generation sequencing (TNGS) panel, using dried blood spots, for second-tier newborn metabolic and hearing loss screening and its immediate utility for high-risk diagnostic testing in the neonatal intensive care unit. 

Oct
29
Sponsored by
Lucigen

This webinar will focus on a range of research and clinical applications enabled by improvements in mate pair technology for whole genome sequencing.